A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, Boehringer Ingelheim International GmbH, BAYER AG, Bristol-Myers Squibb/Pfizer EEIG against the decision of the State Institute for Drug Control from 30. 9. 2019, under the no. SUKLS215786/2013 - I. Under article 90 paragraph 1 letter b) ot the Administrative Code the operative part 2, 3, 4b), 5b), 6b), 12b), 13b), 14b), 15, 16, 17, 18, 19, 20, 21 and 22 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal. II. Under article 90 paragraph 4 in conncetion with article 66 paragraph 2 of the Administrative Code the operative part 10 of the decision under appeal is dismissed and the proceedings are terminated. III. Under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.
More information: MZCR.cz (czech version only)